全文获取类型
收费全文 | 347828篇 |
免费 | 27820篇 |
国内免费 | 15136篇 |
专业分类
耳鼻咽喉 | 3696篇 |
儿科学 | 5915篇 |
妇产科学 | 8908篇 |
基础医学 | 45419篇 |
口腔科学 | 7630篇 |
临床医学 | 38381篇 |
内科学 | 58144篇 |
皮肤病学 | 5117篇 |
神经病学 | 20895篇 |
特种医学 | 12364篇 |
外国民族医学 | 99篇 |
外科学 | 42126篇 |
综合类 | 38286篇 |
现状与发展 | 48篇 |
一般理论 | 78篇 |
预防医学 | 22765篇 |
眼科学 | 9306篇 |
药学 | 33455篇 |
157篇 | |
中国医学 | 11546篇 |
肿瘤学 | 26449篇 |
出版年
2023年 | 3339篇 |
2022年 | 4906篇 |
2021年 | 10750篇 |
2020年 | 8812篇 |
2019年 | 8475篇 |
2018年 | 9458篇 |
2017年 | 8028篇 |
2016年 | 7747篇 |
2015年 | 11389篇 |
2014年 | 14425篇 |
2013年 | 14157篇 |
2012年 | 20849篇 |
2011年 | 22789篇 |
2010年 | 13862篇 |
2009年 | 11285篇 |
2008年 | 15942篇 |
2007年 | 16221篇 |
2006年 | 15765篇 |
2005年 | 15483篇 |
2004年 | 11470篇 |
2003年 | 10321篇 |
2002年 | 9132篇 |
2001年 | 12253篇 |
2000年 | 12589篇 |
1999年 | 11690篇 |
1998年 | 5173篇 |
1997年 | 4792篇 |
1996年 | 3555篇 |
1995年 | 3410篇 |
1994年 | 2988篇 |
1993年 | 2244篇 |
1992年 | 5834篇 |
1991年 | 5644篇 |
1990年 | 5085篇 |
1989年 | 4840篇 |
1988年 | 4540篇 |
1987年 | 4252篇 |
1986年 | 3892篇 |
1985年 | 3589篇 |
1984年 | 2457篇 |
1983年 | 2110篇 |
1982年 | 1172篇 |
1979年 | 2132篇 |
1978年 | 1322篇 |
1975年 | 1274篇 |
1974年 | 1472篇 |
1973年 | 1506篇 |
1972年 | 1428篇 |
1971年 | 1319篇 |
1970年 | 1203篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Chen Zhao Yan Bai Cencen Wang Yanyan Zhong Na Lu Li Tian Fucheng Cai Runming Jin 《International journal of medical sciences》2021,18(1):120
Objective: To evaluate the characteristics at admission of patients with moderate COVID-19 in Wuhan and to explore risk factors associated with the severe prognosis of the disease for prognostic prediction.Methods: In this retrospective study, moderate and severe disease was defined according to the report of the WHO-China Joint Mission on COVID-19. Clinical characteristics and laboratory findings of 172 patients with laboratory-confirmed moderate COVID-19 were collected when they were admitted to the Cancer Center of Wuhan Union Hospital between February 13, 2020 and February 25, 2020. This cohort was followed to March 14, 2020. The outcomes, being discharged as mild cases or developing into severe cases, were categorized into two groups. The data were compared and analyzed with univariate logistic regression to identify the features that differed significantly between the two groups. Based on machine learning algorithms, a further feature selection procedure was performed to identify the features that can contribute the most to the prediction of disease severity.Results: Of the 172 patients, 112 were discharged as mild cases, and 60 developed into severe cases. Four clinical characteristics and 18 laboratory findings showed significant differences between the two groups in the statistical test (P<0.01) and univariate logistic regression analysis (P<0.01). In the further feature selection procedure, six features were chosen to obtain the best performance in discriminating the two groups with a linear kernel support vector machine. The mean accuracy was 91.38%, with a sensitivity of 0.90 and a specificity of 0.94. The six features included interleukin-6, high-sensitivity cardiac troponin I, procalcitonin, high-sensitivity C-reactive protein, chest distress and calcium level.Conclusions: With the data collected at admission, the combination of one clinical characteristic and five laboratory findings contributed the most to the discrimination between the two groups with a linear kernel support vector machine classifier. These factors may be risk factors that can be used to perform a prognostic prediction regarding the severity of the disease for patients with moderate COVID-19 in the early stage of the disease. 相似文献
992.
Ting-Ting Liu Rui Li Xiao Liu Xi-Jia Zhou Chen Huo Jian-Ping Li Yi-Qing Qu 《International journal of medical sciences》2021,18(2):419
Background: In recent years, LncRNA acts as a member of competing endogenous RNA (ceRNA), playing an important role in drug resistance of lung cancer. The aim of this study was to identify potential biomarkers about cisplatin resistant lung cancer cells using a comprehensive ceRNA network.Methods: (GPL-201) analyzed gene expression changes about cisplatin resistance in A549 NSCLC cells. GSE6410 (GPL-14613) included noncoding RNA expression profiling derived from the cisplatin resistant A549 lung cells. GEO2R, an online analysis tool, analyzed the differentially expressed mRNAs and miRNAs (DEmRNAs and DEmiRNAs). To explore the functional enrichment implication of differentially expressed mRNAs, we used the GO (Gene ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis. Through miRDB, Targetscan, Starbase and miRWalk, we found targeted miRNAs. The Kaplan-Meier curve method was used to show clinical survival analysis of targeted RNAs (P<0.05). The Starbase database predicted potential lncRNAs mediated targeted miRNAs. Eventually, the novel ceRNA network of lncRNAs, miRNAs, mRNA was constructed by cytoscape3.7.2.Results: 118 differentially expressed mRNAs were the basis of the mediated ceRNA network. DAVID and Kaplan-Meier picked out BAX, an apoptosis regulator. Venn diagram demonstrated 8 miRNAs commonly regulating BAX. Starbase predicted lncRNA XIST mediated miRNAs. Finally, lncRNA XIST may be a useful biomarker regulating cisplatin resistance in lung cancer cells and further, we explored the BAX may effect tumor-infiltrating immune cells.Conclusions: LncRNA XIST competitively bound to miRNA 520 in the regulation of cisplatin resistance by BAX, participating apoptosis in the p53 signaling pathway. GSE43249相似文献
993.
Dan-Ping Huang Yi-Hao Zeng Wei-Qu Yuan Xiu-Fang Huang Sheng-Qian Chen Mu-Yao Wang Yi-Jun Qiu Guang-Dong Tong 《International journal of medical sciences》2021,18(2):335
Aims: We aimed to explore the crucial miRNA-mRNA axis through bioinformatics analysis and provide evidences for the development of pathophysiological mechanisms and new therapies for HBV-related HCC.Methods: MiRNA () and mRNA ( GSE76903) dataset were used to screen differentially expressed miRNAs (DE-miRNAs) and differentially expressed mRNAs (DE-mRNAs) using R software. Overlapping genes between DE-mRNAs and target genes of DE-miRNAs were identified as candidate genes. Hub genes were obtained via cytohubba analysis. The expression at protein and mRNA levels and prognostic value of hub genes were evaluated based on The Cancer Genome Atlas (TCGA) data. Key miRNA-mRNA axes were constructed according to predicted miRNA-mRNA pairs. MiRNA expression and prognostic role were respectively identified using starBase v3.0 and Kaplan-Meier plotter database. Real-time PCR was performed to verify the expression of crucial miRNAs and mRNAs. Coexpression of crucial miRNA and mRNA were analyzed using starBase v3.0.Results: CDK1, CCNB1, CKS2 and CCNE1 were screened as hub genes, which were significantly upregulated at protein and mRNA levels. These up-regulated hub genes were also significantly associated with poor prognosis. Hsa-mir-195-5p/CDK1, hsa-mir-5589-3p/CCNB1 and hsa-let-7c-3p/CKS2 were screened as critical miRNA-mRNA axes. Critical miRNAs were decreased in HCC, which indicates unfavourable prognosis. QPCR results showed that crucial miRNAs were decreased, whereas critical mRNAs were increased in HBV-related HCC. A reverse relationship between miRNA and mRNA in crucial axis was further verified.Conclusion: This study identified several miRNA-mRNA axes in HBV-related HCC. Hsa-mir-195-5p/CDK1, hsa-mir-5589-3p/CCNB1 and hsa-let-7c-3p/CKS2 might serve as potential prognostic biomarkers and therapeutic targets for HBV-related HCC. GSE77509相似文献
994.
Hypertrophic cardiomyopathy (HCM) is an inherited cardiac disease, which has a marked heterogeneity in clinical expression, natural history, and prognosis. HCM is associated with a high prevalence of thromboembolic events (stroke and systemic embolic events), even if taking no account of atrial fibrillation (AF), leading to unexpected disability and death in patients of all ages. Several risk factors of thromboembolism such as AF, greater age, left atrial diameter, heart failure and others have been confirmed in patients with HCM. Conventional thromboembolic predictive models were estimated by several trials in HCM population but it turned out to be unsatisfactory. Based on those previous explorations, researchers tried to modify or develop novel models suitable for HCM population in thromboembolism prediction. In consideration of catastrophic advent events of thromboembolism, current guidelines have recommended life-long anticoagulant therapy after a single short AF.Therefore, early identification of risk factors for thromboembolism, accurate risk stratification, timely preventive measures and aggressive management may help to avoid serious adverse thromboembolic events in HCM population. 相似文献
995.
基于培育医学生科研素养的创新能力训练体系建立及实施 《医学教育管理》2021,7(1):11
深圳大学医学部自成立以来,注重培育医学生的创新能力和科研素质,构建了“科研导师制—创新实验—项目竞赛”三位一体的科研创新能力训练体系,并逐步形成自己的特色,通过建立有效的科研导师运行及管理机制,以基础医学创新实验系列课程为载体,以国内外医学相关科研大赛为契机,有效促进了医学本科生科研素养和创新能力的提升。2012年以来,医学部临床医学专业90%以上学生通过参与该训练体系的培训,在科研论文发表、科研项目申报、国内外科研竞赛中取得骄人的成绩。 相似文献
996.
997.
本文结合1例胰腺纤维钙化性糖尿病患者的临床资料和文献复习,分析该病的病因、临床表现、诊断标准及治疗、预后等。该病是一种继发于胰腺外分泌疾病的特殊类型糖尿病,主要见于热带发展中国家营养较差的青年人。其特点为胰腺内、外分泌功能同时受累,表现为胰管结石,胰腺钙化及糖尿病。治疗主要包括内科改善营养、控制血糖等及外科胰管取石。临床上容易误诊误治,值得重视。 相似文献
998.
患者女性,44岁。行下肢动脉造影后2h出现心悸、全身不适,3h出现剧烈腰痛伴烦躁不安及大汗,4h右肾区叩痛明显,右侧腰背部可触及一个大而软的肿块,血压降至88/57 mmHg(1 mmHg=0.133 kPa),急诊彩色超声显示右肾周见约9.9 cm×5.6 cm弱回声团,提示右肾肾周血肿,立即给予止血、输血及扩容,并行急诊右肾动脉造影术,显示右肾下极靠近包膜处可见一血管畸形,造影剂外溢,给予弹簧圈栓塞治疗。术后继续对症处理,病情稳定出院,出院随访10个月,未见任何不适。 相似文献
999.
Mohammad A. Zafar Julia Fayanne Chen Jinlin Wu Yupeng Li Dimitra Papanikolaou Mohamed Abdelbaky Thais Faggion Vinholo John A. Rizzo Bulat A. Ziganshin Sandip K. Mukherjee John A. Elefteriades 《The Journal of thoracic and cardiovascular surgery》2021,161(2):498-511.e1
ObjectivesElucidating critical aortic diameters at which natural complications (rupture, dissection, and death) occur is of paramount importance to guide timely surgical intervention. Natural history knowledge for descending thoracic and thoracoabdominal aortic aneurysms is sparse. Our small early studies recommended repairing descending thoracic and thoracoabdominal aortic aneurysms before a critical diameter of 7.0 cm. We focus exclusively on a large number of descending thoracic and thoracoabdominal aortic aneurysms followed over time, enabling a more detailed analysis with greater granularity across aortic sizes.MethodsAortic diameters and long-term complications of 907 patients with descending thoracic and thoracoabdominal aortic aneurysms were reviewed. Growth rates (instrumental variables approach), yearly complication rates, 5-year event-free survival (Kaplan–Meier), and risk of complications as a function of aortic height index (aortic diameter [centimeters]/height [meters]) (competing-risks regression) were calculated.ResultsEstimated mean growth rate of descending thoracic and thoracoabdominal aortic aneurysms was 0.19 cm/year, increasing with increasing aortic size. Median size at acute type B dissection was 4.1 cm. Some 80% of dissections occurred below 5 cm, whereas 93% of ruptures occurred above 5 cm. Descending thoracic and thoracoabdominal aortic aneurysm diameter 6 cm or greater was associated with a 19% yearly rate of rupture, dissection, or death. Five-year complication-free survival progressively decreased with increasing aortic height index. Hazard of complications showed a 6-fold increase at an aortic height index of 4.2 or greater compared with an aortic height index of 3.0 to 3.5 (P < .05). The probability of fatal complications (aortic rupture or death) increased sharply at 2 hinge points: 6.0 and 6.5 cm.ConclusionsAcute type B dissections occur frequently at small aortic sizes; thus, prophylactic size-based surgery may not afford a means for dissection protection. However, fatal complications increase dramatically at 6.0 cm, suggesting that preemptive intervention before that criterion can save lives. 相似文献
1000.